Purpose of the development: New highly vitamin-mineral preparation "Kalmivid M" is intended for the treatment of osteoporosis as well as prophylaxis of diseases associated with bone loss.

Recommended application field: Medicine. For patients with diseases of the musculoskeletal system.

Advantages over analogues: Preparation of known analogs "Kalmivid M" characterized in that it contains vitamin D3 in the form of a complex with casein protein, which considerably increases the resistance against the influence of vitamin D3 detergents gastrointestinal tract and prevents the formation of toxic oxidation products thereof. "Kalmivid-M" is a modification of the drug "Kalmivid" and have a higher efficiency of therapeutic effects on the structural and functional state of the bone tissue and epiphyseal cartilage.

The development stage readiness: tested in laboratory condition

Description of the development:
()
Preparation "Kalmivid M" contains vitamin D3 in the form of a complex with casein protein, which considerably increases the resistance against the influence of vitamin D3 detergents gastrointestinal tract and prevents the formation of toxic oxidation products thereof. The structure includes mineral components calcium, zinc, copper and manganese, rational dosage which corresponds to the optimal physiological effects on the human body. The drug is highly effective therapeutic action on structural-functional state of the bone tissue and epiphyseal cartilage, bioavailability of calcium, phosphorus normalization of metabolism in the body.

Information about newness of the development:
there are Ukrainian patents -- 1 items

corresponds technical description
Guarantees stable results getting

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua